Inogen (INGN) Net Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.00% |
| Dec 31, 2025 | -3.39% |
| Sep 30, 2025 | 61.55% |
| Jun 30, 2025 | -39.52% |
| Mar 31, 2025 | -13.23% |
| Dec 31, 2024 | -27.70% |
| Sep 30, 2024 | 16.37% |
| Jun 30, 2024 | -17.59% |
| Mar 31, 2024 | -23.14% |
| Dec 31, 2023 | -45.68% |
| Sep 30, 2023 | -44.84% |
| Jun 30, 2023 | -21.54% |
| Mar 31, 2023 | -31.99% |
| Dec 31, 2022 | -29.92% |
| Sep 30, 2022 | -23.77% |
| Jun 30, 2022 | 1.40% |
| Mar 31, 2022 | -30.72% |
| Dec 31, 2021 | -23.33% |
| Sep 30, 2021 | 14.47% |
| Jun 30, 2021 | 8.98% |
| Mar 31, 2021 | 5.82% |
| Dec 31, 2020 | -17.12% |
| Sep 30, 2020 | -15.83% |
| Jun 30, 2020 | 21.03% |
| Mar 31, 2020 | 19.54% |
| Dec 31, 2019 | 128.19% |
| Sep 30, 2019 | -34.98% |
| Jun 30, 2019 | 20.09% |
| Mar 31, 2019 | -16.41% |
| Dec 31, 2018 | 50.70% |
| Sep 30, 2018 | 27.87% |
| Jun 30, 2018 | 206.46% |
| Mar 31, 2018 | 68.58% |